trending Market Intelligence /marketintelligence/en/news-insights/trending/adel-5ee03mcz8jrtdsyqg2 content esgSubNav
In This List

PharmAust CEO resigns

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


PharmAust CEO resigns

PharmAust Ltd. said Richard Hopkins resigned as CEO to pursue a senior corporate position at another company, effective May 25.

The company's executive chairman, Roger Aston, will become PharmAust's acting CEO following Hopkins' departure.

Australia's PharmAust operates as a drug discovery and development company primarily in Australia and Switzerland.